HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)

CNY 8.18

(-5.43%)

Operating Expenses Summary of HPGC Renmintongtai Pharmaceutical Corporation

  • HPGC Renmintongtai Pharmaceutical Corporation's latest annual operating expenses in 2023 was 586.72 Million CNY , down -7.95% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation's latest quarterly operating expenses in 2024 Q3 was 127.41 Million CNY , up 11.47% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a annual operating expenses of 540.62 Million CNY in annual operating expenses 2022, down -5.64% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a annual operating expenses of 572.91 Million CNY in annual operating expenses 2021, down -12.34% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly operating expenses of 127.41 Million CNY for 2024 Q3, up 11.47% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly operating expenses of 127 Million CNY for 2024 Q1, down -10.82% from previous quarter.

Annual Operating Expenses Chart of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Historical Annual Operating Expenses of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Year Operating Expenses Operating Expenses Growth
2023 586.72 Million CNY -7.95%
2022 540.62 Million CNY -5.64%
2021 572.91 Million CNY -12.34%
2020 653.54 Million CNY 7.04%
2019 610.53 Million CNY 11.17%
2018 549.21 Million CNY -3.49%
2017 569.06 Million CNY 3.91%
2016 547.65 Million CNY -19.61%
2015 681.25 Million CNY -10.1%
2014 757.83 Million CNY -38.7%
2013 1.23 Billion CNY -22.94%
2012 1.6 Billion CNY 19.34%
2011 1.34 Billion CNY 20.35%
2010 1.11 Billion CNY 16.99%
2009 954.85 Million CNY -4.92%
2008 1 Billion CNY 18.01%
2007 851.03 Million CNY 19.77%
2006 710.54 Million CNY 27.52%
2005 557.18 Million CNY 170.69%
2004 205.83 Million CNY 73.21%
2003 118.83 Million CNY -5.93%
2002 126.32 Million CNY 10.35%
2001 114.47 Million CNY 14.39%
2000 100.07 Million CNY 9.37%
1999 91.5 Million CNY 10.49%
1998 82.81 Million CNY 24.45%
1997 66.54 Million CNY -7.19%
1996 71.7 Million CNY 24.8%
1995 57.45 Million CNY 2218.72%
1994 2.47 Million CNY -94.98%
1993 49.34 Million CNY 18.22%
1992 41.73 Million CNY 13.47%
1991 36.78 Million CNY 13.28%
1990 32.47 Million CNY 0.0%

Peer Operating Expenses Comparison of HPGC Renmintongtai Pharmaceutical Corporation

Name Operating Expenses Operating Expenses Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.61 Billion CNY 87.28%
Yabao Pharmaceutical Group Co., Ltd 1.43 Billion CNY 59.195%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 9.06 Billion CNY 93.529%
Harbin Pharmaceutical Group Co., Ltd. 3.39 Billion CNY 82.704%
Tasly Pharmaceutical Group Co., Ltd 4.56 Billion CNY 87.15%
Zhejiang Medicine Co., Ltd. 2.14 Billion CNY 72.636%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2.52 Billion CNY 76.729%
Lionco Pharmaceutical Group Co.,Ltd. 235.93 Million CNY -148.678%
Humanwell Healthcare (Group) Co.,Ltd. 7.77 Billion CNY 92.455%
Ginwa Enterprise (Group) Inc. 473.93 Million CNY -23.797%
Joincare Pharmaceutical Group Industry Co.,Ltd. 6.84 Billion CNY 91.424%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 334.81 Million CNY -75.237%
China Animal Husbandry Industry Co., Ltd. 665.77 Million CNY 11.874%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 516.66 Million CNY -13.559%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.89 Billion CNY 84.94%
Shanghai Haoyuan Chemexpress Co., Ltd. 720.84 Million CNY 18.606%
Ningbo Menovo Pharmaceutical Co., Ltd. 323.95 Million CNY -81.11%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 904.15 Million CNY 35.108%
Chongqing Taiji Industry(Group) Co.,Ltd 6.47 Billion CNY 90.932%
Nanjing Well Pharmaceutical Group Co.,Ltd. 195.02 Million CNY -200.841%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.58 Billion CNY 63.024%
Henan Lingrui Pharmaceutical Co., Ltd. 1.77 Billion CNY 66.866%
Shenzhen Chipscreen Biosciences Co., Ltd. 617.41 Million CNY 4.971%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.73 Billion CNY 66.241%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.04 Billion CNY 80.755%
Zhongzhu Healthcare Holding Co.,Ltd 281 Million CNY -108.797%
Beijing Tongrentang Co., Ltd 5.21 Billion CNY 88.76%
KPC Pharmaceuticals, Inc. 2.88 Billion CNY 79.656%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 679.56 Million CNY 13.663%
North China Pharmaceutical Company Ltd. 3.05 Billion CNY 80.806%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 4.1 Billion CNY 85.69%
Tibet Weixinkang Medicine Co., Ltd. 497.13 Million CNY -18.02%
China National Medicines Corporation Ltd. 1.04 Billion CNY 43.957%
Zhejiang Hisun Pharmaceutical Co., Ltd. 3.96 Billion CNY 85.197%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 859.39 Million CNY 31.729%
ChengDu ShengNuo Biotec Co.,Ltd. 196.27 Million CNY -198.934%
Dali Pharmaceuticalco.,Ltd 56.92 Million CNY -930.611%
Changchun BCHT Biotechnology Co. 1.08 Billion CNY 46.033%
Zhejiang Shengda Bio-Pharm Co., Ltd. 119.2 Million CNY -392.19%
Shanghai Jiaoda Onlly Co.,Ltd 92.17 Million CNY -536.5%
Jiang Zhong Pharmaceutical Co.,Ltd 1.97 Billion CNY 70.262%
Mayinglong Pharmaceutical Group Co., LTD. 778.04 Million CNY 24.59%
Cisen Pharmaceutical Co., Ltd. 2.01 Billion CNY 70.881%
Hunan Warrant Pharmaceutical Co.,Ltd 691.12 Million CNY 15.106%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 17.16 Billion CNY 96.581%
Jianmin Pharmaceutical Group Co.,Ltd. 1.56 Billion CNY 62.601%
Hunan Fangsheng Pharmaceutical Co., Ltd. 912.55 Million CNY 35.706%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.77 Billion CNY 66.857%
Guobang Pharma Ltd. 550.06 Million CNY -6.664%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 245.55 Million CNY -138.939%
Kangmei Pharmaceutical Co., Ltd. 628.4 Million CNY 6.634%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.48 Billion CNY 93.088%
Zhejiang Starry Pharmaceutical Co.,Ltd. 484.13 Million CNY -21.189%
Henan Taloph Pharmaceutical Stock Co.,Ltd 520.55 Million CNY -12.71%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.28 Billion CNY 54.511%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.19 Billion CNY 73.299%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 334.18 Million CNY -75.566%
Shanghai Shyndec Pharmaceutical Co., Ltd. 3.54 Billion CNY 83.446%
Shanghai Yizhong Pharmaceutical Co., Ltd. 175.02 Million CNY -235.22%
Tibet Rhodiola Pharmaceutical Holding Co. 2.07 Billion CNY 71.746%
Sichuan Huiyu Pharmaceutical Co., Ltd. 672.26 Million CNY 12.724%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 249.26 Million CNY -135.381%
CanSino Biologics Inc. 1.49 Billion CNY 60.694%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 869.22 Million CNY 32.501%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.18 Billion CNY 50.639%